Overview

• US District Judge Royce Lamberth granted a preliminary injunction preventing the Bureau of Prisons from enforcing guidance based on President Trump’s executive order that would have cut off funds for gender-affirming treatment.
• The ruling certifies a class of all federal inmates receiving hormone therapy for gender dysphoria, extending protections beyond the three initial plaintiffs.
• Before the executive order, the Bureau of Prisons was providing hormone therapy to more than 600 of the roughly 1,000 inmates diagnosed with gender dysphoria.
• Attorneys for the inmates documented that halting hormone therapy led to severe psychological distress, including anxiety, panic attacks, and suicidal thoughts.
• The decision affirms that prison officials cannot arbitrarily override medical recommendations deemed appropriate by their own clinicians.